Argyle Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.76M Sell
38,995
-400
-1% -$29.9K 0.9% 41
2025
Q4
$3.11M Buy
39,395
+1,742
+5% +$138K 1.04% 37
2025
Q3
$3.1M Hold
37,653
1.07% 35
2025
Q2
$3.03M Buy
37,653
+450
+1% +$34.7K 1.1% 34
2025
Q1
$2.99M Buy
37,203
+1,720
+5% +$143K 1.11% 36
2024
Q4
$2.91M Buy
35,483
+1,483
+4% +$123K 1.14% 36
2024
Q3
$2.8M Sell
34,000
-1,575
-4% -$118K 1.12% 34
2024
Q2
$2.5M Sell
35,575
-50
-0.1% -$3.57K 1.03% 39
2024
Q1
$2.64M Sell
35,625
-1,900
-5% -$132K 1.02% 42
2023
Q4
$2.48M Sell
37,525
-9,200
-20% -$576K 1.03% 40
2023
Q3
$2.94M Hold
46,725
1.08% 36
2023
Q2
$2.64M Sell
46,725
-2,050
-4% -$114K 0.95% 39
2023
Q1
$2.83M Sell
48,775
-200
-0.4% -$13.5K 0.99% 40
2022
Q4
$3.54M Sell
48,975
-1,500
-3% -$107K 1.22% 31
2022
Q3
$3.07M Hold
50,475
1.2% 33
2022
Q2
$3.17M Hold
50,475
1.14% 37
2022
Q1
$3.55M Sell
50,475
-3,400
-6% -$230K 1.15% 37
2021
Q4
$3.37M Hold
53,875
1.05% 42
2021
Q3
$3.33M Buy
53,875
+50
+0.1% +$3.01K 1.1% 42
2021
Q2
$3.22M Hold
53,825
1.04% 44
2021
Q1
$3.27M Hold
53,825
1.1% 40
2020
Q4
$2.53M Hold
53,825
0.94% 46
2020
Q3
$2M Buy
53,825
+2,500
+5% +$94.9K 0.82% 50
2020
Q2
$1.87M Hold
51,325
0.79% 50
2020
Q1
$1.57M Hold
51,325
0.74% 50
2019
Q4
$2.62M Sell
51,325
-700
-1% -$33.8K 0.93% 48
2019
Q3
$2.45M Sell
52,025
-200
-0.4% -$9.54K 0.93% 49
2019
Q2
$2.59M Hold
52,225
0.98% 48
2019
Q1
$2.22M Hold
52,225
0.85% 50
2018
Q4
$2.14M Buy
52,225
+1,500
+3% +$64.4K 0.91% 47
2018
Q3
$2.37M Buy
50,725
+1,000
+2% +$45.7K 0.89% 45
2018
Q2
$2.17M Buy
49,725
+400
+0.8% +$18.6K 0.86% 51
2018
Q1
$2.26M Sell
49,325
-2,100
-4% -$102K 0.9% 50
2017
Q4
$2.6M Hold
51,425
0.97% 47
2017
Q3
$2.67M Sell
51,425
-6,274
-11% -$306K 1.05% 42
2017
Q2
$2.83M Sell
57,699
-561
-1% -$26K 1.15% 38
2017
Q1
$2.74M Buy
58,260
+561
+1% +$26.7K 1.12% 41
2016
Q4
$2.77M Sell
57,699
-1,010
-2% -$46.3K 1.18% 36
2016
Q3
$2.33M Sell
58,709
-1,234
-2% -$46.4K 1.01% 45
2016
Q2
$2.13M Buy
59,943
+7,742
+15% +$302K 0.9% 48
2016
Q1
$2.04M Buy
52,201
+2,356
+5% +$88.1K 0.93% 46
2015
Q4
$2.14M Sell
49,845
-28
-0.1% -$1.23K 0.99% 44
2015
Q3
$2.1M Buy
49,873
+1,459
+3% +$68.2K 1.02% 42
2015
Q2
$2.42M Sell
48,414
-674
-1% -$31.9K 1.11% 39
2015
Q1
$2.21M Hold
49,088
0.99% 46
2014
Q4
$2.37M Buy
49,088
+1,459
+3% +$69.3K 1.04% 39
2014
Q3
$2.28M Hold
47,629
1.05% 42
2014
Q2
$2.36M Buy
+47,629
New +$2.23M 1.1% 40

Other funds holding MET

Argyle Capital Management's MET Position: Q1 2026 in Review

Argyle Capital Management reduced its MetLife (MET) stake by 1% in Q1 2026, selling an estimated $29.9K and leaving 38,995 shares worth $2.76M. The position accounts for 0.9% of the portfolio, ranked #41.

Argyle Capital Management first reported a position in MET in Q2 2014 and has held it in 48 quarters since. The position peaked at $3.55M in Q1 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Argyle Capital Management held 38,995 shares of MetLife worth $2.76M as of Q1 2026.
  • Argyle Capital Management sold 400 MetLife shares in Q1 2026, an estimated $29.9K.
  • MetLife made up 0.9% of Argyle Capital Management's portfolio in Q1 2026, its #41 holding.
  • Argyle Capital Management first reported a position in MetLife in Q2 2014 and has held it in 48 quarters since.
  • Argyle Capital Management's MetLife position peaked at $3.55M in Q1 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.